Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ChronoScale Holdings CorpEKSO · Entity 4331 | Director | August 31, 2017 | September 05, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ChronoScale Holdings Corp
Report date August 31, 2017 · Filed September 05, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,492 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Other · Acquired 6,634 · Balance 9,492 F1: On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights. F2: The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 3,317 shares of common stock. The reporting person also exercised in full his over-subscription rights for an additional 3,317 shares of common stock. |
| Subscription Rights (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.00 · Expires 2017-08-31 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-31 · Other · Disposed 2,858 · Balance 0 |
Filing footnotes · ownership attribution and instrument terms
F1: On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights.
F2: The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 3,317 shares of common stock. The reporting person also exercised in full his over-subscription rights for an additional 3,317 shares of common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2017 Filed Sep 5, 2017 22:15 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | OtherSubscription Rights (right to buy) · Derivative | 2,858 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001455244-17-000030 · edgar.xml · derivative · entry 2 Boren Daniel · CIK 0001640217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,634 shares Expires 2017-08-31 Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 22:15 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | OtherCommon Stock | 6,634 | $1.00 | $6,634.00 |
DisclosureSEC source: 0001455244-17-000030 · edgar.xml · nonDerivative · entry 1 Boren Daniel · CIK 0001640217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,492 F1 · shares: On August 14, 2017, Ekso Bionics Holdings, Inc. (the "Company") issued a press release announcing the commencement of a pro rata offering (the "Rights Offering") of rights to holders of the Company's common stock and certain holders of warrants issued by the Company, as of the record date of August 10, 2017, to subscribe for up to an aggregate of 34,000,000 shares of common stock. Each subscription right included a basic subscription right, which entitled its holder to purchase 1.1608 shares of common stock at a subscription price of $1.00, and an over-subscription right, which entitled its holder to purchase up to 1.1608 shares of common stock at a subscription price of $1.00, subject to the availability and pro rata allocation of shares among rights holders exercising their over-subscription rights. F2 · shares: The reporting person exercised in full his basic subscription rights, pursuant to which he acquired 3,317 shares of common stock. The reporting person also exercised in full his over-subscription rights for an additional 3,317 shares of common stock. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:14 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001455244-17-000011 · edgar.xml · derivative · entry 1 Boren Daniel · CIK 0001640217 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-07-05 F1 · derivative.exercise_date: The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.